期刊文献+
共找到33篇文章
< 1 2 >
每页显示 20 50 100
Binding of EGF1 Domain Peptide in Coagulation Factor Ⅶ with Tissue Factor and Its Implications for the Triggering of Coagulation 被引量:3
1
作者 梅恒 胡豫 +3 位作者 王华芳 石威 邓君 郭涛 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2010年第1期42-47,共6页
The binding function of EGF1 domain peptide with tissue factor(TF)and its ability of triggering coagulation were explored.The TF expression model in vitro was established by lipopolysaccha-ride induction.The affinity ... The binding function of EGF1 domain peptide with tissue factor(TF)and its ability of triggering coagulation were explored.The TF expression model in vitro was established by lipopolysaccha-ride induction.The affinity of EGFP-EGF1 and TF expressing cells was analyzed by fluorescence microscopy and flow cytometry(FCM).The affinity of EGFP-EGF1 and rat soluble TF was quantitated by surface plasmon resonance(SPR).The ability of EGFP-EGF1 in triggering coagulation was tested by prothrombin time assay.The FCM res... 展开更多
关键词 coagulation factor epidermal growth factor-like domain tissue factor ANTICOAGULATION
下载PDF
Coagulation factor Ⅶ gene polymorphisms are not associated with the occurrence or the survival of hepatocellular carcinoma:a report of 37 cases
2
作者 Chih-Che Lin Chun-Hsien Wu +3 位作者 Li-Yu Chen Ming-Chao Tsai Ahmed M.Elsarawy Kuang-Tzu Huang 《Cancer Biology & Medicine》 SCIE CAS CSCD 2018年第3期275-281,共7页
Objective: Coagulation factor VII(FVII) triggers the extrinsic pathway of blood coagulation. In our previous study, we showed that FVII plays an important role in tumorigenesis of hepatocellular carcinoma(HCC). Howeve... Objective: Coagulation factor VII(FVII) triggers the extrinsic pathway of blood coagulation. In our previous study, we showed that FVII plays an important role in tumorigenesis of hepatocellular carcinoma(HCC). However, the role of FVII polymorphism in HCC is still unknown. The present study aimed to investigate the relationship between HCC carcinogenesis and single nucleotide polymorphism of FVII.Methods: Thirty-seven HCC patients and 30 healthy donors were recruited in this study. Four common FVII gene polymorphisms– a decanucleotide insertion at position –323(–323 ins10-bp), a G to T substitution at position –401(–401 G/T), a G to A substitution at position –402(–402 G/A), and a T to C substitution at position –122(–122 T/C) – were analyzed by sequencing or commercialized assays using genomic DNA isolated from blood samples. Clinicopathological parameters between control and HCC subjects were compared according to the specific genotypes.Results: The most common nucleotide variation was –402 G/A. However, no statistically significant difference was observed between healthy controls and HCC subjects for all four polymorphisms in terms of genotype distribution and allele frequencies,indicating that these polymorphisms may not affect HCC tumorigenesis. Furthermore, no association was found between–402 G/A polymorphisms and tumor stage, recurrence, and overall survival.Conclusions: Our results indicate that FVII polymorphisms may not be a key factor that clinically impact tumorigenesis and outcomes of HCC, although further investigations should be conducted to confirm our findings. 展开更多
关键词 factor gene POLYMORPHISM liver HEPATOCELLULAR cancer SURVIVAL
下载PDF
Role of Coagulation Factor Ⅶ in Pathogenesis of Ischemic Heart Disease
3
作者 胡豫 徐丹梅 +4 位作者 孙春艳 褚章波 郑金娥 王华芳 魏文宁 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2006年第6期657-660,共4页
To study the variation and significance of plasma coagulation factor Ⅶ (FⅦ) in different kinds of ischemia heart disease (IHD) and examine its relation with plasma lipid and gene polymorphism. FⅦa was determine... To study the variation and significance of plasma coagulation factor Ⅶ (FⅦ) in different kinds of ischemia heart disease (IHD) and examine its relation with plasma lipid and gene polymorphism. FⅦa was determined with one stage clotting assay by using a recombinant soluble tissue factor (rsTF). FⅦc was measured with one stage clotting assay. FⅦag was quantified with an enzyme-linked immunosorbent assay (ELISA). Polymorphism was analyzed with PCR-urea-polyacrylamide gel electrophoresis. Our results showed that FⅦa in stable angina (SA), unstable angina (UA), obsolete and acute myocardial infraction (OMI, AMI) patients was higher than those of normal group with the differences being significant within any two groups. FⅦag in UA, OMI and AMI was higher than those in SA and normal groups. There were positive correlations between FⅦa and serum triglycerides, FⅦa and FⅦc, FⅦc and FⅦag. FⅦ-323 0/10 bp polymorphism analysis was performed in 60 patients and 0/10 bp polymorphism was found in 5 cases. FⅦc and FⅦag were much lower in cases of 0/10 bp groups than those in cases of 0/0 bp groups. It is concluded that there was activation of extrinsic coagulation pathway in every kind of IHD to different extent. FⅦa was the risk factor in the development of IHD, and more sensitive in reflecting the severity of cardiovacutar disease than FⅦc or FⅦag. FⅦa was higher in OMI, which may be one of the risk factors of re-infraction. Serum triglyceride may indirectly lead to the development of IHD by increasing the level of FⅦa, FⅦ-323 0/10 bp polymorphism was present in Chinese patients with IHD and it was correlated with the level of FⅦc, FⅦag in plasma. 10 bp allelomorphic gene was a protective factor against thrombogenesis. 展开更多
关键词 factor ischemic heart disease LIPID -323 0/10 bp polymorphism
下载PDF
因子Ⅶa依赖组织因子激活PAR2/ERK/NF-κB抑制结肠癌SW620细胞caspase-3表达 被引量:5
4
作者 张先梅 周红 +4 位作者 陈东东 解鸿翔 胡丽超 武标 吴莺 《临床检验杂志》 CAS CSCD 北大核心 2012年第4期284-288,共5页
目的探讨凝血因子Ⅶa对结肠癌SW620细胞增殖能力以及表达凋亡分子天冬氨酸特异性半胱氨酸蛋白酶3(caspase-3)的影响及其作用机制。方法用一定剂量的蛋白酶激活受体2激动剂(PAR2-AP)、凝血因子Ⅶa等刺激物处理SW620细胞,观察细胞生长情况... 目的探讨凝血因子Ⅶa对结肠癌SW620细胞增殖能力以及表达凋亡分子天冬氨酸特异性半胱氨酸蛋白酶3(caspase-3)的影响及其作用机制。方法用一定剂量的蛋白酶激活受体2激动剂(PAR2-AP)、凝血因子Ⅶa等刺激物处理SW620细胞,观察细胞生长情况;western blot和定量PCR分别检测细胞表达caspase-3蛋白质及mRNA水平;利用相关抗体、拮抗剂和抑制剂等观察因子Ⅶa对caspase-3表达的效应变化。结果 PAR2-AP(100μmol/L)及因子Ⅶa(10 nmol/L)能够明显促进SW620细胞的生长,减少细胞caspase-3蛋白质和mRNA的表达;抗组织因子(TF)抗体(а-TF)、PAR2拮抗剂(PAR2-аAP)、ERK1/2抑制剂U0126以及NF-κB抑制剂PDTC均能逆转因子Ⅶa对SW620细胞caspase-3表达的抑制效应,而p38MAPK抑制剂SB203580对caspase-3的表达无明显的干预作用。结论因子Ⅶa依赖TF活化PAR2,经ERK1/2和NF-κB信号通路,抑制SW620细胞caspase-3表达,从而促进细胞的增殖与生长。 展开更多
关键词 凝血因子ⅶa 组织因子 蛋白酶激活受体2 天冬氨酸特异性半胱氨酸蛋白酶3
下载PDF
人重组凝血因子Ⅶa在Stanford A型主动脉夹层手术止血中的应用 被引量:2
5
作者 池闯 何志锋 +1 位作者 刘瑜 孙成超 《中国临床药理学与治疗学》 CAS CSCD 2013年第5期524-526,共3页
目的:评价人重组凝血因子Ⅶa在Stanford A型主动脉夹层手术止血中的疗效。方法:对12例手术中使用人重组凝血因子Ⅶa的患者和20例未使用人重组凝血因子Ⅶa的患者进行回顾性分析,观察手术止血时间,术后24h引流量,术后24h浓缩红细胞使用量... 目的:评价人重组凝血因子Ⅶa在Stanford A型主动脉夹层手术止血中的疗效。方法:对12例手术中使用人重组凝血因子Ⅶa的患者和20例未使用人重组凝血因子Ⅶa的患者进行回顾性分析,观察手术止血时间,术后24h引流量,术后24h浓缩红细胞使用量,术后24h血浆使用量。结果:rFⅦa组的手术止血时间明显缩短,与对照组比较差异具有统计学意义[(166±33)min vs(206±48)min,P<0.05];rFⅦa组术后24h引流量低于对照组[(666±195)mL vs(824±210)mL,P<0.05];rFⅦa组术后24h血浆使用量低于对照组[(525±157)mL vs(696±211)mL,P<0.05];rFⅦa组术后24h浓缩红细胞使用量与对照组无统计学差异[(3.2±1.3)Uvs(3.9±1.9)U,P>0.05]。结论:在Stanford A型主动脉夹层手术中使用人重组凝血因子Ⅶa有良好的止血效果,可缩短手术时间,减少引流量,节约血制品的使用。 展开更多
关键词 人重组凝血因子ⅶa 主动脉夹层 止血
下载PDF
FⅦa依赖TF及FⅩ活化PAR2上调SW 620细胞IL-8表达 被引量:4
6
作者 石文霞 周红 +2 位作者 李娜 黄宏亮 周保成 《血栓与止血学》 2009年第2期53-56,共4页
目的探讨凝血FⅦa、Ⅹ、Ⅱa在蛋白酶激活受体2(PAR2)活化及诱导SW620细胞IL-8表达中的作用。方法用PAR2激动剂(PAR2-AP)、FⅦa、Ⅹ、Ⅱa等不同刺激物处理SW620细胞,以ELISA法检测细胞上清IL-8水平,以实时定量PCR检测细胞IL-8mRNA表达。... 目的探讨凝血FⅦa、Ⅹ、Ⅱa在蛋白酶激活受体2(PAR2)活化及诱导SW620细胞IL-8表达中的作用。方法用PAR2激动剂(PAR2-AP)、FⅦa、Ⅹ、Ⅱa等不同刺激物处理SW620细胞,以ELISA法检测细胞上清IL-8水平,以实时定量PCR检测细胞IL-8mRNA表达。结果血浆浓度的Ⅶa需在FⅩ存在下才能促进细胞IL-8表达;单克隆抗TF及抗PAR2抗体均可抑制FⅦa的作用;FⅡa轻微下调细胞IL-8表达,Hirudin、抗PAR1及抗PAR2抗体均可阻断此作用。结论TF-FⅦa及TF-FⅦa-FⅩa复合物,而非FⅡa,活化PAR2上调SW620细胞IL-8表达,从而促进细胞增殖及迁移。 展开更多
关键词 蛋白酶激活受体2(PAR2) 因子ⅶa 白介素-8(IL-8) 结肠癌细胞株SW 620
下载PDF
EGCG对因子Ⅶa促进SW620细胞增殖与迁移的干预作用及机制 被引量:1
7
作者 周芳 周红 +3 位作者 吴莺 郭东琳 许国莹 文海平 《实用肿瘤杂志》 CAS 2012年第1期28-32,共5页
目的探讨表没食子儿茶素没食子酸酯(EGCG)对因子Ⅶa促进SW620细胞增殖与迁移的干预作用及机制。方法用EGCG、因子Ⅶa等处理SW620细胞,应用流式细胞术、Transwell法分别检测细胞增殖周期及迁移能力;Western blotting检测细胞NF-κB抑制蛋... 目的探讨表没食子儿茶素没食子酸酯(EGCG)对因子Ⅶa促进SW620细胞增殖与迁移的干预作用及机制。方法用EGCG、因子Ⅶa等处理SW620细胞,应用流式细胞术、Transwell法分别检测细胞增殖周期及迁移能力;Western blotting检测细胞NF-κB抑制蛋白(IκB-α)、核NF-κB(p65/RelA)的蛋白水平变化。结果 EGCG(100 mg/L)能干预因子Ⅶa对SW620细胞增殖与迁移的促进作用;EGCG能抑制因子Ⅶa对IκB-α表达的下调作用及对核NF-κB(p65/RelA)表达的促进作用。结论 EGCG可能通过干预信号分子IκB-α和NF-κB(p65/RelA)的表达和调节作用,抑制因子Ⅶa对SW620细胞增殖与迁移的促进作用。 展开更多
关键词 结肠肿瘤 EGCG 因子ⅶa 肿瘤细胞 培养的 增殖 迁移
下载PDF
组织因子/活化凝血Ⅶ因子复合物对大肠癌LoVo细胞系表达基质金属蛋白酶-7的调控作用 被引量:1
8
作者 汤坚强 万远廉 +5 位作者 刘玉村 戎龙 汪欣 吴涛 潘义生 朱静 《北京大学学报(医学版)》 CAS CSCD 北大核心 2007年第5期453-457,共5页
目的:观察活化凝血Ⅶ因子(actived factorⅦ,FⅦa)对大肠癌LoVo细胞系表达基质金属蛋白酶-7(ProMMP-7)的影响,探讨其可能的组织因子信号转导通路。方法:(1)用Western blot检测100nmol/L FⅦa刺激LoVo细胞系不同时间点及不同浓度FⅦa刺激... 目的:观察活化凝血Ⅶ因子(actived factorⅦ,FⅦa)对大肠癌LoVo细胞系表达基质金属蛋白酶-7(ProMMP-7)的影响,探讨其可能的组织因子信号转导通路。方法:(1)用Western blot检测100nmol/L FⅦa刺激LoVo细胞系不同时间点及不同浓度FⅦa刺激LoVo细胞系12h后细胞ProMMP-7蛋白水平;用Western blot检测5mg/L组织因子(tissue factor,TF)抗体预孵育LoVo细胞系0.5h后再给予100nmol/L FⅦa刺激12h后细胞ProM-MP-7蛋白水平。(2)观察用100nmol/L FⅦa刺激时丝裂原激活蛋白激酶(MAPKs)各亚通路信号蛋白(包括细胞外信号调节激酶ERK1/2,丝裂原激活蛋白激酶P38及c-Jun-N末端蛋白激酶JNK)磷酸化水平变化。(3)在FⅦa刺激前0.5h分别加入ERK1/2,P38和JNK信号通路特异阻断剂PD98059,SB203580和SP600125,培养12h后检测细胞ProMMP-7蛋白的变化。结果:(1)FⅦa可刺激LoVo系细胞表达ProMMP-7并呈时间依赖性和剂量依赖性,在刺激的12h左右ProMMP-7达峰值,是正常对照组的5.5±0.6倍(P=0.006);用TF抗体预处理的LoVo细胞系,其FⅦa上调ProMMP-7表达的作用被完全阻断。(2)用100nmol/L FⅦa刺激LoVo细胞5min时,MAPKs磷酸化活性蛋白p-ERK1/2和p-P38表达水平开始增加,至10min时达峰值(分别为对照组的2.2±0.3倍和3.9±0.5倍,P值分别为0.02和0.01),存在时间效应关系,而p-JNK活性无改变(为对照组的1.1±0.1倍)。(3)ERK1/2通路阻断剂PD98059及P38通路阻断剂SB203580可部分减少FⅦa上调LoVo细胞系表达ProMMP-7的效应,分别降低了32%±5%(P=0.01)和61%±10%(P=0.009),JNK通路特异性阻断剂SP600125对ProMMP-7的表达无明显影响。结论:FⅦa通过与LoVo细胞表面的TF结合诱导ProMMP-7的表达,并呈时间依赖性和剂量依赖性;ERK1/2和P38MAPKs亚通路参与LoVo细胞TF信号转导通路并与TF/FⅦa调控ProMMP-7表达有关。 展开更多
关键词 因子ⅶa 结直肠肿瘤 基质金属蛋白酶类 丝裂原激活蛋白激酶类
下载PDF
重组人凝血因子Ⅶa用于高危心脏手术后严重出血治疗的回顾性分析 被引量:2
9
作者 郑铁 郭可泉 +1 位作者 王坚刚 孟旭 《心肺血管病杂志》 CAS 2010年第2期124-127,共4页
目的:总结重组人凝血因子Ⅶa(rFⅦa)治疗高危心脏手术后严重出血的治疗经验。方法:对2006年10月至2007年6月13例高危心脏手术后严重出血的患者应用rFⅦa治疗后进行回顾性分析。其中男性9例,女性4例,年龄5~60岁,平均38岁。手术包括主动... 目的:总结重组人凝血因子Ⅶa(rFⅦa)治疗高危心脏手术后严重出血的治疗经验。方法:对2006年10月至2007年6月13例高危心脏手术后严重出血的患者应用rFⅦa治疗后进行回顾性分析。其中男性9例,女性4例,年龄5~60岁,平均38岁。手术包括主动脉手术6例,瓣膜置换术5例,心脏移植1例,复杂先天性心脏病(先心病)1例,监测应用rFⅦa前后的治疗效果及不良反应。结果:应用rFⅦa后,心包及纵隔引流量明显减少〔(1136±348)mL对比(318±114)mL,P<0.005〕;凝血酶原时间(PT)明显缩短〔(16.8±5.9)s对比(11.3±3.3)s,P<0.05〕;国际标准化比值(INR)明显减小〔(1.3±0.4)对比(0.9±0.3),P<0.05〕;活化部分凝血活酶时间(APTT)则在用药前后差异无统计学意义〔(53.2±8.8)s对比(45.6±8.2)s,P=0.355〕。术后死亡1例(死亡原因为多器官功能衰竭),远期发生脑梗死1例。未发现心肌梗死及其他血栓性并发症。结论:对于高危心脏手术后的严重大出血的患者,及时应用rFⅦa可获得满意的治疗效果,可减少引流量,降低血液制品的输注,且不良反应发生率低。 展开更多
关键词 重组人凝血因子ⅶa 心脏围手术期处理 心脏术后严重出血 心脏外科手术 心脏疾病
下载PDF
重组凝血因子Ⅶa对体外循环人工心脏瓣膜置换术后早期恢复的影响
10
作者 麻彬 王志农 +4 位作者 张宝仁 徐志云 杨立信 陈克彪 李健 《第二军医大学学报》 CAS CSCD 北大核心 2006年第10期1110-1113,共4页
目的:评价重组凝血因子Ⅶa(rFⅦa)应用于体外循环(CPB)人工心脏瓣膜置换术后对患者早期恢复的疗效。方法:22例心脏瓣膜病行CPB人工心脏瓣膜置换术的患者,随机分为rFⅦa组及安慰剂组,rFⅦa组于术中注射鱼精蛋白后应用rFⅦa,安慰剂组应用... 目的:评价重组凝血因子Ⅶa(rFⅦa)应用于体外循环(CPB)人工心脏瓣膜置换术后对患者早期恢复的疗效。方法:22例心脏瓣膜病行CPB人工心脏瓣膜置换术的患者,随机分为rFⅦa组及安慰剂组,rFⅦa组于术中注射鱼精蛋白后应用rFⅦa,安慰剂组应用安慰剂。rFⅦa组于术前、术中肝素化后、注射鱼精蛋白前、注射鱼精蛋白后应用rFⅦa前以及应用rFⅦa后15 min、45 min、2 h、24 h、120 h共9个时间点分别采血查血常规及各项凝血指标。安慰剂组应用生理盐水代替rFⅦa,并在相同的时间点采血检测。观察每例患者术后的胸液引流量、术后输血量、呼吸机辅助时间、ICU停留时间及总住院费用等指标。结果:rFⅦa组患者术后均达到满意止血,无栓塞性并发症及术后早期死亡。血浆凝血酶原时间(PT)在应用rFⅦa后15 min为(14.1±3.0)s,45 min为(13.5±1.7)s,2 h后为(11.6±1.2)s,这3个时间点的PT与安慰剂组相比均具有显著统计学差异(P<0.01)。凝血酶原国际标准化比值(INR)在注射rFⅦa后15 min为1.05±0.26,45 min为0.93±0.16,2 h后为1.04±0.19,这3个时间点的PT与安慰剂组相比均具有显著统计学差异(P<0.01)。术后胸腔引流液量、异体输血量、呼吸机辅助时间I、CU停留时间较安慰剂组明显减少,而总住院费用两组无明显差异。结论:rFⅦa能有效地改善CPB人工心脏瓣膜置换术后的凝血功能,减少异体输血需求,且无明显不良反应,有利于患者早期恢复。 展开更多
关键词 心肺转流术 重组凝血因子ⅶa 凝血 输血
下载PDF
TF/Ⅶa活化PAR2后经钙信号促进SW620细胞的增殖和迁移
11
作者 吴莺 王静 +3 位作者 余小燕 胡丽超 武标 周红 《临床检验杂志》 CAS CSCD 北大核心 2013年第3期190-193,199,共5页
目的探讨钙信号参与凝血因子Ⅶa依赖组织因子(TF)激活蛋白酶活化受体2(PAR2),从而促进结肠癌SW620细胞增殖、迁移的可能机制。方法Ⅶa(10 nmol/L)及PAR2激动剂(PAR2-AP,100μmol/L)作用负载fluo-4/AM的SW620细胞,激光共聚焦显微镜测定... 目的探讨钙信号参与凝血因子Ⅶa依赖组织因子(TF)激活蛋白酶活化受体2(PAR2),从而促进结肠癌SW620细胞增殖、迁移的可能机制。方法Ⅶa(10 nmol/L)及PAR2激动剂(PAR2-AP,100μmol/L)作用负载fluo-4/AM的SW620细胞,激光共聚焦显微镜测定细胞内钙离子荧光强度的变化;钙抑制剂EGTA(1 mmol/L)和毒胡萝卜内酯(thapsigargin,TG,1μmol/L)预处理细胞后,Ⅶa(10 nmol/L)、PAR2-AP(100μmol/L)再分别处理细胞,western blot检测p-ERK1/2、t-ERK1/2蛋白的表达;MTT法及流式细胞术检测SW620细胞的增殖情况、transwell法检测细胞迁移的变化。结果Ⅶa(10 nmol/L)和PAR2-AP(100μmol/L)处理SW620细胞后,胞内钙离子荧光强度瞬时升高后降低,分别在60、30 s达到峰值;EGTA和TG预处理细胞,能明显降低Ⅶa、PAR2-AP对p-ERK1/2蛋白的活化作用(P<0.05),抑制其对细胞增殖和迁移的促进作用。结论 TF/Ⅶa激活PAR2后,经钙信号通路活化下游ERK1/2信号,促进SW620细胞的增殖和迁移。 展开更多
关键词 结肠癌细胞SW620 凝血因子ⅶa 蛋白酶激活受体2 钙信号 细胞外信号调节激酶1 2
下载PDF
小剂量重组凝血因子Ⅶa对肝移植凝血功能的影响 被引量:1
12
作者 董长江 周松花 《吉林医药学院学报》 2007年第4期187-190,共4页
目的探讨小剂量重组凝血因子Ⅶa对肝移植凝血功能的影响。方法11例行原位肝移植术病人于无肝前期使用重组凝血因子Ⅶa2.4mg(30~40μg/kg)。记录给药前15min和给药后15min血栓弹性图(TEG)参数(r、k、α、MA和LY60),同时记录给药前后血... 目的探讨小剂量重组凝血因子Ⅶa对肝移植凝血功能的影响。方法11例行原位肝移植术病人于无肝前期使用重组凝血因子Ⅶa2.4mg(30~40μg/kg)。记录给药前15min和给药后15min血栓弹性图(TEG)参数(r、k、α、MA和LY60),同时记录给药前后血浆凝血酶原时间、活化部分凝血活酶时间、纤维蛋白原含量和血小板计数。结果使用重组凝血因子Ⅶa前后TEG参数相比较,差异无统计学意义(P>0.05);用药后血浆凝血酶原时间缩短,差异有统计学意义(P<0.05)。结论小剂量重组凝血因子Ⅶa(30~40μg/kg)对TEG参数无影响,但是可缩短血浆凝血酶原时间。 展开更多
关键词 肝移植 重组凝血因子ⅶa 凝血 血栓弹性图
下载PDF
重组活化凝血因子Ⅶa与脑出血后神经细胞凋亡 被引量:1
13
作者 黄海华 梁志坚 《医学综述》 2010年第18期2764-2766,共3页
重组活化凝血因子Ⅶa(rFⅦa)作为一种强效的止血剂能够有效地减少超早期脑出血的血肿体积继续扩大。然而,近年来的研究显示,rFⅦa可以通过促进凝血酶的产生,减少红细胞裂解以及减少细胞凋亡酶的生成等途径抑制脑出血后神经细胞凋亡,发... 重组活化凝血因子Ⅶa(rFⅦa)作为一种强效的止血剂能够有效地减少超早期脑出血的血肿体积继续扩大。然而,近年来的研究显示,rFⅦa可以通过促进凝血酶的产生,减少红细胞裂解以及减少细胞凋亡酶的生成等途径抑制脑出血后神经细胞凋亡,发挥神经保护作用。 展开更多
关键词 重组活化凝血因子ⅶa 脑出血 细胞凋亡 神经保护
下载PDF
Calcium-dependent activation of CPK12 facilitates its cytoplasm-to-nucleus translocation to potentiate plant hypoxia sensing by phosphorylating ERF-Ⅶ transcription factors 被引量:1
14
作者 Biao Fan Ke Liao +8 位作者 Lin-Na Wang Li-Li Shi Yi Zhang Ling-Jing Xu Ying Zhou Jian-Feng Li Yue-Qin Chen Qin-Fang Chen Shi Xiao 《Molecular Plant》 SCIE CSCD 2023年第6期979-998,共20页
Calcium-dependent protein kinases(CDPKs/CPKs)are key regulators of plant stress signaling that translate calcium signals into cellular responses by phosphorylating diverse substrate proteins.However,the molecular mech... Calcium-dependent protein kinases(CDPKs/CPKs)are key regulators of plant stress signaling that translate calcium signals into cellular responses by phosphorylating diverse substrate proteins.However,the molecular mechanism by which plant cells relay calcium signals in response to hypoxia remains elusive.Here,we show that one member of the CDPK family in Arabidopsis thaliana,CPK12,is rapidly activated during hypoxia through calcium-dependent phosphorylation of its Ser-186 residue.Phosphorylated CPK12 shuttles from the cytoplasm to the nucleus,where it interacts with and phosphorylates the group Ⅶ ethylene-responsive transcription factors(ERF-Ⅶ)that are core regulators of plant hypoxia sensing,to enhance their stabilities.Consistently,CPK12 knockdown lines show attenuated tolerance of hypoxia,whereas transgenic plants overexpressing CPK12 display improved hypoxia tolerance.Nonethelss,loss of function of five ERF-Ⅶ proteins in an erf-vii pentuple mutant could partially suppress the enhanced hypoxia-tolerance phenotype of CPK12-overexpressing lines.Moreover,we also discovered that phosphatidic acid and 14-3-3κ protein serve as positive and negative modulators of the CPK12 cytoplasm-to-nucleus translocation,respectively.Taken together,these findings uncover a CPK12-ERF-Ⅶ regulatory module that is key to transducing calcium signals from the cytoplasm into the nucleus to potentiate hypoxia sensing in plants. 展开更多
关键词 CPK12 hypoxia sensing cytoplasm-to-nucleus translocation ERF-transcription factors phospha-tidic acid 14-3-3 proteins
原文传递
肝移植术后早期腹腔出血及其处理的探讨 被引量:1
15
作者 赖添顺 郭振辉 +3 位作者 孙杰 唐柚青 霍枫 苏磊 《血栓与止血学》 2008年第2期74-77,共4页
目的观察肝移植术后早期腹腔出血的相关因素,分析不同处理对预后的影响。方法对我院行肝移植手术后早期发生腹腔出血患者的围手术期各种相关因素进行观察,并观察保守治疗及手术止血治疗对预后影响。结果肝移植患者术前存在不同程度的凝... 目的观察肝移植术后早期腹腔出血的相关因素,分析不同处理对预后的影响。方法对我院行肝移植手术后早期发生腹腔出血患者的围手术期各种相关因素进行观察,并观察保守治疗及手术止血治疗对预后影响。结果肝移植患者术前存在不同程度的凝血功能障碍,术后凝血功能较术前差。发生腹腔出血患者原发病大多为肝炎后肝硬化,术前MELD评分较正常组高(P<0.01)。保守处理组凝血功能较手术组要差且并发症多死亡率高。而在手术后止血使用重组活化凝血因子Ⅶa有引起肝动脉栓塞的风险。结论肝移植术后腹腔出血患者,应立刻给予保守治疗,如出血仍无法控制时,应尽快进行手术治疗。重组活化凝血因子Ⅶa有肝动脉栓塞的危险,不宜使用。 展开更多
关键词 肝移植 腹腔出血 保守治疗 重组活化凝血因子ⅶa
下载PDF
Association of coagulation factor Ⅶ with the risk of myocardial infarction in the Chinese 被引量:2
16
作者 蔡强军 陈纪林 +2 位作者 马会利 宋杰 许敏伏 《Chinese Medical Journal》 SCIE CAS CSCD 2000年第12期3-7,共5页
To elucidate the association of plasma factor Ⅶ coagulant activity (FⅦc) with the risk of myocardial infarction (MI) and to assess the influence of factor Ⅶ gene MspI polymorphism and lipid metabolism on FⅦc... To elucidate the association of plasma factor Ⅶ coagulant activity (FⅦc) with the risk of myocardial infarction (MI) and to assess the influence of factor Ⅶ gene MspI polymorphism and lipid metabolism on FⅦc in the Chinese Methods A total of 137 patients with angiographically confirmed MI and 125 healthy individuals were evaluated retrospectively Plasma FⅦc was measured by one stage prothrombin time, and FⅦ genotype was determined after MspI digestion of polymerase chain reaction amplified genomic DNA Serum lipid levels were assessed by routine methods Results MI patients had significantly higher levels of FⅦc (119 5%±22 7% vs 99 9%±21 8%, P <0 01) and total serum cholesterol (5 80±1 06?mmol/L vs 5 53±1 08?mmol/L, P <0 05) than controls, but only FⅦc independently correlated with the risk of MI (OR=1 04, P <0 01) There were no significant differences in FⅦ genotype or allele frequency between patients and controls ( P >0 05) Subjects with the Gln353 allele were associated with significantly lower FⅦc levels than Arg353 homozygotes (99 7%±19 3% vs 111 4%±24 6%, P <0 05) Serum triglyceride was positively correlated with plasma FⅦc in both control ( r =0 25, P <0 01) and case ( r =0 87, P <0 01) groups, but this correlation was restricted to Arg/Arg genotype ( r =0 68, P <0 01) A significant correlation of total serum cholesterol with FⅦc only appeared in Arg/Arg homozygotes ( r =0 17, P <0 01) Conclusions Our findings support the role of plasma FⅦc as a risk factor for MI in Chinese Plasma triglyceride and FⅦ gene MspI polymorphism are two independent determinants of FⅦc Assay of this polymorphism will be helpful in determining who will benefit most from lipid lowing therapy 展开更多
关键词 coagulation factor · gene polymorphism · TRIGLYCERIDE · myocardial infarcti`
原文传递
Polymorphisms of the coagulation factor Ⅶ gene and its plasma levels in relation to acute cerebral infarction differences in allelic frequencies between Chinese Han and European populations 被引量:9
17
作者 康文英 王鸿利 +7 位作者 熊立凡 王学锋 储海燕 璩斌 刘湘帆 尹俊 段宝华 王振义 《Chinese Medical Journal》 SCIE CAS CSCD 2004年第1期71-74,共4页
Background Coagulation factor Ⅶ (F Ⅶ) levels in plasma are usually related to ischemic heart disease (IHD) and cerebral infarction shares many of the risk factors related to IHD. Is there any relationship between ... Background Coagulation factor Ⅶ (F Ⅶ) levels in plasma are usually related to ischemic heart disease (IHD) and cerebral infarction shares many of the risk factors related to IHD. Is there any relationship between factor Ⅶ and cerebral infarction? We investigated the relationship between F Ⅶ and acute cerebral infarction and reported genotype frequencies and allelic frequencies of FⅦ gene polymorphisms in the Chinese Han population. Methods We recruited 62 patients with acute cerebral infarction confirmed by magnetic resonance imaging (MRI) from Ruijin Hospital,and 149 age-matched patients clinically free of vascular disease to act as controls. All of them were unrelated,and were from the Chinese Han population. FⅦ coagulant activity (FⅦc) was determined using an clotting assay,activated FⅦ (FⅦa) and FⅦ Ag were assayed using enzyme immunoassay kits. The FⅦ gene polymorphisms to be detected included-401G/T,-402G/A,5’F7A1/A2,IVS7 and R353Q. 5’F7 and IVS7 were revealed by means of a PCR and direct agarose gel electrophoresis. The rest were examined by a polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP). Results The results showed that FⅦc,FⅦAg and FⅦa were higher in the acute cerebral infarction group than in the control group ( P <0.01, P <0.05, P <0.05,respectively). There were no significant differences in the genotype frequencies of FⅦ gene polymorphisms between the two groups. The allelic frequencies in the Chinese Han population were as follows: -401G/T (96.64/3.36), -402G/A (52.01/47.99),5’F7A1/A2(96.64/3.36),IVS7 H5/H6/H7/H8 (0.34/52.35/46.98/0.34) and R353Q (95.64/4.36). There were significant differences ( P <0.01, P <0.001, P <0.001, P <0.001, P <0.001,respectively) in these allelic frequencies between the Chinese Han and European populations. Conclusions The results indicate that increased plasma FⅦ levels may contribute to thrombosis in cerebral infarction. And there was no significant difference in genotype frequencies of these five FⅦ gene polymorphisms between the acute cerebral infarction and control groups. Moreover,these results showed that the frequencies of protective allele, including -401T,5’F7 A2 and 353Q were lower, but that -402A, which was previously found to be associated with increased plasma FⅦ levels,is higher in Chinese Han population. 展开更多
关键词 coagulation factor ·cerebral infarction·polymorphism
原文传递
Polymorphisms in the coagulation factor Ⅶ gene and the risk of myocardial infarction in patients undergoing coronary angiography 被引量:4
18
作者 徐耕 金国栋 +4 位作者 傅国胜 马骥 施育平 唐欧杉 单江 《Chinese Medical Journal》 SCIE CAS CSCD 2003年第8期1194-1197,共4页
Objective To investigate whether coagulation factor Ⅶ (FⅦ) polymorphisms play a role in the pathogenesis of coronary artery disease (CAD) and/or myocardial infarction (MI) in a series of Hans.Methods The Arg 35... Objective To investigate whether coagulation factor Ⅶ (FⅦ) polymorphisms play a role in the pathogenesis of coronary artery disease (CAD) and/or myocardial infarction (MI) in a series of Hans.Methods The Arg 353 Gln and HVR4 polymorphisms of FⅦ gene were determined in 374 patients undergoing selective coronary angiography by PCR and restriction fragment length polymorphism assay.Results The FⅦ genotype distribution was in accordance with Hardy-Weinberg equilibrium. The frequencies of FⅦ genotypes or alleles did not show significant differences between the CAD group and the controls or between the males and the females. The frequencies of carriers of the Gln 353 allele and (Arg/Gln+Gln/Gln) genotypes were significantly higher in the CAD patients without MI than in those with MI ( P =0.031,odds ratio 0.37,95% CI: 0.15-0.94). However,HVR4 polymorphisms were not significantly different between the two groups ( P >0.05).Conclusion Carrying the F Ⅶ Gln 353 gene may be a protective factor against MI in the Chinese Hans. 展开更多
关键词 coagulation factor ·genes·polymorphism · coronary angiography·myocardial infarction
原文传递
RELATIONSHIP AMONG MYOCARDIAL INFARCTION, INSERTION/DELETION POLYMORPHISM OF FVII GENE PROMOTER REGION AND FVII ACTIVITY
19
作者 陶蓉 于金德 +7 位作者 陆林 乐玮 尤蓓 陈颖 龚兰生 曹文俊 黄薇 朱鼎良 《Journal of Shanghai Second Medical University(Foreign Language Edition)》 2004年第1期18-21,共4页
Objective To explore the relationship among myocardial infarction (MI) , promoter regionpolymorphism of FVII gene and FVII activity in a Chinese population. Methods Denaturing gradient gel electro-phoresis technique w... Objective To explore the relationship among myocardial infarction (MI) , promoter regionpolymorphism of FVII gene and FVII activity in a Chinese population. Methods Denaturing gradient gel electro-phoresis technique was used to study promoter region polymorphism of FVII gene, and plasma FVII activity (FVIIC) was examined by one stage clotting assay in 74 cases with MI as well as 123 normal controls. Results An insertion/deletion polymorphism of 10bp was found in the promoter region. Plasma FVII activity was significantly higher in the myocardial infarction (P <0. 05). Conclusion Elevated FVII activity may be a risk factor for myocardial infarction. There is no correlation found between the insertion/deletion polymorphism of FVII gene promoter region and myocardial infarction in a Chinese population (74 MI cases and 123 normal controls). 展开更多
关键词 factor myocardial infarction PCR-denaturing gradient gel electrophoresis
下载PDF
组织因子/活化因子Ⅶ复合物影响人卵巢癌细胞侵袭及转移能力的研究 被引量:9
20
作者 方峻 魏文宁 +1 位作者 夏凌辉 宋善俊 《中华血液学杂志》 CAS CSCD 北大核心 2004年第9期523-527,共5页
目的 研究组织因子 /活化因子Ⅶ (TF/FⅦa)复合物对人卵巢癌细胞体外侵袭能力及体内转移能力的影响。方法 ①采用分子克隆及基因转染技术构建高效表达TF的人卵巢癌细胞系A2 780 /TF ;②采用Boyden小室法计数FⅦa刺激后A2 780、A2 780 ... 目的 研究组织因子 /活化因子Ⅶ (TF/FⅦa)复合物对人卵巢癌细胞体外侵袭能力及体内转移能力的影响。方法 ①采用分子克隆及基因转染技术构建高效表达TF的人卵巢癌细胞系A2 780 /TF ;②采用Boyden小室法计数FⅦa刺激后A2 780、A2 780 /TF穿透Matrigel迁移到PVPF膜背面的细胞数 ;③建立人卵巢癌细胞转移的实验动物模型 ,研究TF对人卵巢癌细胞在裸鼠体内形成转移灶的能力。结果 ①经分子克隆技术构建得到pcDNA3 TFcDNA重组体 ;②稳定转染的A2 780 /TF细胞内TFmRNA水平显著增高 :转染细胞为 3.99± 0 .15 ,未转染细胞为 0 .97± 0 .2 3(P <0 .0 1) ;转染细胞表面TF表达也显著增高 :转染细胞中约 (48.5 6± 9.5 3) %细胞表面有TF抗原 ,而未转染细胞中仅 (2 .73± 1.15 ) % (P <0 .0 1) ;③A2 780 /TF细胞穿膜细胞数为 15 7.3± 19.2 ,经FⅦa刺激后穿膜细胞数显著增多 ,为 4 4 7.7± 39.4 (P <0 .0 1) ;与FⅦa和抗TF单抗共孵育的A2 780 /TF ,穿膜细胞数接近刺激前的基础水平 ;④种植A2 780细胞的裸鼠中 2 2 .2 %可见肺部转移灶 ,种植A2 780 /TF细胞的裸鼠中 88.9%发生肺转移 (P <0 .0 1)。结论 ①将所构建的TF真核表达载体转入人卵巢癌细胞系 ,获得稳定、高效表达TF的人卵巢癌细胞系A2 780 /TF 。 展开更多
关键词 人卵巢癌细胞系 TF 细胞数 因子 体内 转染细胞 裸鼠 高效表达 DNA重组 mRNA水平
原文传递
上一页 1 2 下一页 到第
使用帮助 返回顶部